A new OCVA-led clinical trial explores time-restricted eating’s potential to improve mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease patients through circadi...
Breakthrough NLC formulations enhance bioavailability of curcumin and EGCG, demonstrating 40% wrinkle reduction through dual collagen protection and SIRT1 activation, per 2024 clinical trials. Recent ...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
Recent studies show nanostructured lipid carriers significantly boost the bioavailability and efficacy of curcumin and EGCG in anti-aging skincare formulations. Breakthrough research reveals how nanos...
Recent studies show NLCs improve delivery of curcumin and EGCG, boosting their anti-aging benefits through enhanced skin penetration and SIRT1 activation. NLCs loaded with curcumin and EGCG show promi...
New research shows prenatal PFAS exposure reduces maternal HOMA-β by 34%, with epigenetic and oxidative stress markers providing mechanistic insights. Global regulatory responses are evolving. A grou...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
New research shows curcumin-EGCG nanoformulations boost collagen production by 40% while improving skin penetration by 80%, revolutionizing anti-aging skincare. Cutting-edge nano-delivery systems are ...
A 12-week TRE intervention with 6-8h eating windows demonstrates potential benefits for HD patients by improving mitochondrial function and cognitive scores, though adherence challenges remain. Emergi...
Recent studies suggest time-restricted eating may offer neuroprotective benefits for Huntington’s disease by improving mitochondrial function and reducing oxidative stress. Emerging research indicat...
